BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15250738)

  • 1. Nature of the peroxo intermediate of the W48F/D84E ribonucleotide reductase variant: implications for O2 activation by binuclear non-heme iron enzymes.
    Skulan AJ; Brunold TC; Baldwin J; Saleh L; Bollinger JM; Solomon EI
    J Am Chem Soc; 2004 Jul; 126(28):8842-55. PubMed ID: 15250738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic and spectroscopic studies of the non-heme reduced binuclear iron sites of two ribonucleotide reductase variants: comparison to reduced methane monooxygenase and contributions to O2 reactivity.
    Wei PP; Skulan AJ; Mitić N; Yang YS; Saleh L; Bollinger JM; Solomon EI
    J Am Chem Soc; 2004 Mar; 126(12):3777-88. PubMed ID: 15038731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxo-type intermediates in class I ribonucleotide reductase and related binuclear non-heme iron enzymes.
    Jensen KP; Bell CB; Clay MD; Solomon EI
    J Am Chem Soc; 2009 Sep; 131(34):12155-71. PubMed ID: 19663382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O2 activation by non-heme diiron proteins: identification of a symmetric mu-1,2-peroxide in a mutant of ribonucleotide reductase.
    Moënne-Loccoz P; Baldwin J; Ley BA; Loehr TM; Bollinger JM
    Biochemistry; 1998 Oct; 37(42):14659-63. PubMed ID: 9778340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of the peroxodiiron(III) intermediate generated during oxygen activation by the W48A/D84E variant of ribonucleotide reductase protein R2 from Escherichia coli.
    Baldwin J; Krebs C; Saleh L; Stelling M; Huynh BH; Bollinger JM; Riggs-Gelasco P
    Biochemistry; 2003 Nov; 42(45):13269-79. PubMed ID: 14609338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (Mu-1,2-peroxo)diiron(III/III) complex as a precursor to the diiron(III/IV) intermediate X in the assembly of the iron-radical cofactor of ribonucleotide reductase from mouse.
    Yun D; García-Serres R; Chicalese BM; An YH; Huynh BH; Bollinger JM
    Biochemistry; 2007 Feb; 46(7):1925-32. PubMed ID: 17256972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectroscopic and computational studies of the de novo designed protein DF2t: correlation to the biferrous active site of ribonucleotide reductase and factors that affect O2 reactivity.
    Wei PP; Skulan AJ; Wade H; DeGrado WF; Solomon EI
    J Am Chem Soc; 2005 Nov; 127(46):16098-106. PubMed ID: 16287296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a chemical trigger for electron transfer to characterize a precursor to cluster X in assembly of the iron-radical cofactor of Escherichia coli ribonucleotide reductase.
    Saleh L; Krebs C; Ley BA; Naik S; Huynh BH; Bollinger JM
    Biochemistry; 2004 May; 43(20):5953-64. PubMed ID: 15147179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable coordination geometries at the diiron(II) active site of ribonucleotide reductase R2.
    Voegtli WC; Sommerhalter M; Saleh L; Baldwin J; Bollinger JM; Rosenzweig AC
    J Am Chem Soc; 2003 Dec; 125(51):15822-30. PubMed ID: 14677973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and spectroscopic characterization of (mu-hydroxo or mu-oxo)(mu-peroxo)diiron(III) complexes: models for peroxo intermediates of non-heme diiron proteins.
    Zhang X; Furutachi H; Fujinami S; Nagatomo S; Maeda Y; Watanabe Y; Kitagawa T; Suzuki M
    J Am Chem Soc; 2005 Jan; 127(3):826-7. PubMed ID: 15656607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ferroxidase reaction of ferritin reveals a diferric mu-1,2 bridging peroxide intermediate in common with other O2-activating non-heme diiron proteins.
    Moënne-Loccoz P; Krebs C; Herlihy K; Edmondson DE; Theil EC; Huynh BH; Loehr TM
    Biochemistry; 1999 Apr; 38(17):5290-5. PubMed ID: 10220314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of NO adducts of the diiron center in protein R2 of Escherichia coli ribonucleotide reductase and site-directed variants; implications for the O2 activation mechanism.
    Lu S; Libby E; Saleh L; Xing G; Bollinger JM; Moënne-Loccoz P
    J Biol Inorg Chem; 2004 Oct; 9(7):818-27. PubMed ID: 15311337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational reprogramming of the R2 subunit of Escherichia coli ribonucleotide reductase into a self-hydroxylating monooxygenase.
    Baldwin J; Voegtli WC; Khidekel N; Moënne-Loccoz P; Krebs C; Pereira AS; Ley BA; Huynh BH; Loehr TM; Riggs-Gelasco PJ; Rosenzweig AC; Bollinger JM
    J Am Chem Soc; 2001 Jul; 123(29):7017-30. PubMed ID: 11459480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediation by indole analogues of electron transfer during oxygen activation in variants of Escherichia coli ribonucleotide reductase R2 lacking the electron-shuttling tryptophan 48.
    Saleh L; Kelch BA; Pathickal BA; Baldwin J; Ley BA; Bollinger JM
    Biochemistry; 2004 May; 43(20):5943-52. PubMed ID: 15147178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geometric and electronic structure studies of the binuclear nonheme ferrous active site of toluene-4-monooxygenase: parallels with methane monooxygenase and insight into the role of the effector proteins in O2 activation.
    Schwartz JK; Wei PP; Mitchell KH; Fox BG; Solomon EI
    J Am Chem Soc; 2008 Jun; 130(22):7098-109. PubMed ID: 18479085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of two self-hydroxylating ribonucleotide reductase protein R2 mutants: structural basis for the oxygen-insertion step of hydroxylation reactions catalyzed by diiron proteins.
    Logan DT; deMaré F; Persson BO; Slaby A; Sjöberg BM; Nordlund P
    Biochemistry; 1998 Jul; 37(30):10798-807. PubMed ID: 9692970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear resonance vibrational spectroscopy and DFT study of peroxo-bridged biferric complexes: structural insight into peroxo intermediates of binuclear non-heme iron enzymes.
    Park K; Tsugawa T; Furutachi H; Kwak Y; Liu LV; Wong SD; Yoda Y; Kobayashi Y; Saito M; Kurokuzu M; Seto M; Suzuki M; Solomon EI
    Angew Chem Int Ed Engl; 2013 Jan; 52(4):1294-8. PubMed ID: 23225363
    [No Abstract]   [Full Text] [Related]  

  • 18. Tridentate copper ligand influences on heme-peroxo-copper formation and properties: reduced, superoxo, and mu-peroxo iron/copper complexes.
    Kim E; Helton ME; Lu S; Moënne-Loccoz P; Incarvito CD; Rheingold AL; Kaderli S; Zuberbühler AD; Karlin KD
    Inorg Chem; 2005 Oct; 44(20):7014-29. PubMed ID: 16180864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational self-hydroxylation: a probe for oxygen activation mechanisms in non-heme iron enzymes.
    Farquhar ER; Koehntop KD; Emerson JP; Que L
    Biochem Biophys Res Commun; 2005 Dec; 338(1):230-9. PubMed ID: 16165090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further insights into the spectroscopic properties, electronic structure, and kinetics of formation of the heme-peroxo-copper complex [(F8TPP)FeIII-(O2(2-)-CuII(TMPA)]+.
    Ghiladi RA; Chufan EE; del Río D; Solomon EI; Krebs C; Huynh BH; Huang HW; Moënne-Loccoz P; Kaderli S; Honecker M; Zuberbühler AD; Marzilli L; Cotter RJ; Karlin KD
    Inorg Chem; 2007 May; 46(10):3889-902. PubMed ID: 17444630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.